Review Article
Haema 2023; 14(1-4):6-10
Michael D. Diamantidis1, George Vassilopoulos2
1Thalassemia and Sickle Cell Disease Unit, Department of Hematology, General Hospital of Larissa, Larissa, Greece
2University of Thessaly Medical School, Head, Division of Hematology, Larisa University Hospital, Affiliate Investigator, Cell and Gene Therapy Lab, BRFAA Athens, Greece
Full PDF | 
Review Article
Haema 2023; 14(1-4):16-20
Eleftheria Hatzimichael,1,2 Epameinondas Koumpis1, Elisavet Apostolidou1
1Department of Haematology, University Hospital of Ioannina
2Faculty of Medicine, School of Health Sciences, University of Ioannina
Full PDF |
Continue reading “Post ASH 2022: Key studies in chronic lymphocytic leukemia (CLL)”
Review Article
Haema 2023; 14(1-4):6-10
Michael D. Diamantidis1, George Vassilopoulos2
1Thalassemia and Sickle Cell Disease Unit, Department of Hematology, General Hospital of Larissa, Larissa, Greece,
2University of Thessaly Medical School, Head, Division of Hematology, Larisa University Hospital, Affiliate Investigator, Cell and Gene Therapy Lab, BRFAA Athens, Greece
Full PDF |
Review Article
Haema 2022; 13(1-2):20-30
Maria Dimou
Hematology Clinical Trial Unit, Hematology and Bone Marrow Transplantation Clinic, National and Kapodistrian University of Athens, Greece
Full PDF |
Continue reading “The Role of Venetoclax in the Treatment of Acute Myeloid Leukemia”